The establishment of a DNA synthesis and construction foundry at Imperial College in London heralds a new chapter in the development of synthetic biology to meet new global challenges. The Foundry employs the latest technology to make the process of engineering biology easier, faster and scalable. The integration of advanced software, automation and analytics allows the rapid design, build and testing of engineered organisms.
Introduction
training, funding for proof of concept and development of prototypes and business support. An important element in the innovation programmes SynbiCITE provides is access to its laboratory facilities, including -the Foundry. This access provides scientists and researchers with a maker space for the rapid translation of ideas and designs: producing a prototype or generating critical data -all geared towards advancing technology, removing the technical uncertainty and risk in the process. This facility is available to SynbiCITE's extensive network of partners including 17 U.K. universities and over 50 industrial and commercial partners, made-up of multinational companies, SMEs and start-ups.
Focus
SynbiCITE with its specific focus on commercial translation employs the Foundry to provide a suite of state-of-theart robotic and analytical equipment supplying end-to-end design, construction and characterization capability to its partners. Work is focused on industry-led projects with commercial or practical applications, which can benefit from the Foundry's automated higher throughput and capacity. The Foundry as part of SynbiCITE, the national IKC for Synthetic Biology, will provide access, collaboration and training opportunities to U.K. companies interested in synthetic biology. 4. Provide support and training programmes. The Foundry, in collaboration with its partners, act as a focal point for the training of researchers (both academic and industrial) in the synthesis and construction of DNA, at scale, in relation to synthetic biology applications.
Facilities and resources
The Foundry's facilities and resources are available to all SynbiCITE academic and industrial partners -providing access to both equipment and expertise. A list of all the equipment is available at www.synbicite.com. To keep abreast of the fast pace of technology development in synthetic biology, the facilities and resources available at the Foundry will evolve to meet demand. The Foundry has continued access to the latest cutting edge technology, required to stimulate innovation in synthetic biology, is made possible through a number of special collaborations with industrial partners supplying resources and expertise. People with the correct skills are key to the successful adoption of synthetic biology by industry. We also recognize that this new industry depends on people with the right skillset to translate their ideas. SynbiCITE is therefore committed to sharing new approaches and discoveries in synthetic biology with its partners by providing scientific workshops and technical training on all equipment and platforms.
A major aim of the Foundry (and synthetic biology) is to make the design and engineering of biological systems systematic and standardized around a 'design-build-testreport-learn' cycle. The Foundry has been specifically built to support and exploit this framework.
The facilities and accompanying capabilities include:
r A range of commercial and proprietary BioCAD/CAM tools for the rapid and scalable design of transgenes and experiments.
r Conventional and acoustic liquid handling robotic platforms to build and assemble multiple DNA components in parallel. Supported by software for programming and scheduling automation.
r A suite of high-throughput analytical/test equipment for metadata acquisition allowing characterization and quantification across the range of biological products.
r A web-based Laboratory Information Management System (LIMS) to report on the tracking of the workflow for any assembly or experiment. The LIMS tracks the users' specifications containing the product design, the entire construction sequence including replicating reagents, PCR and assembly; and the sample reagent lineage, location and availability.
r The engineering-design cycle is completed with data analytics, providing the learn capability with statistical interpretation and modelling which can feedback into the design loop.
The Foundry and SynbiCITE, both represent a unique public-private collaborative effort to accelerate and promote business exploitation of emerging research and technology around synthetic biology. The Foundry intends to deliver a key resource to the U.K. synthetic biology industrial and academic community seeking to commercialize their ideas and research.
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